Poor Quality Pharmaceuticals in Global Public Health
This book aims to clarify the global aspects of poor quality pharmaceuticals, generic products in particular, becoming complicated through the process of IMPACT (International Medical Products Anti-Counterfeiting Taskforce) organized by the initiative of the World Health Organization (WHO) in 2006....
| Main Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Singapore
Springer Nature Singapore
2020, 2020
|
| Edition: | 1st ed. 2020 |
| Series: | Trust, Interdisciplinary Perspectives
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Preface
- Global aspect of imitated products and poor quality pharmaceuticals
- Problem awareness among the WHO and other major international organizations
- Precedent academic works and media reports
- Bias or misleading by the WHO?
- Standardization and its advantages in globalization
- Global events associated with modern medicines
- WHO medicines policy in public health
- IMPACT and conflicts of international society
- Case study I: Access to medicines in Indonesia
- Case study II: Supply side of medicines in India
- Case study III: Health-care service market in Japan
- An interpretation and lessons to learn